HCA Healthcare, Inc. $HCA Shares Bought by Darsana Capital Partners LP

Darsana Capital Partners LP grew its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 46.7% in the second quarter, Holdings Channel reports. The institutional investor owned 1,100,000 shares of the company’s stock after acquiring an additional 350,000 shares during the quarter. HCA Healthcare accounts for 1.9% of Darsana Capital Partners LP’s holdings, making the stock its 6th largest holding. Darsana Capital Partners LP’s holdings in HCA Healthcare were worth $428,879,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently added to or reduced their stakes in the company. Cidel Asset Management Inc. lifted its holdings in HCA Healthcare by 8.0% during the second quarter. Cidel Asset Management Inc. now owns 1,585 shares of the company’s stock valued at $618,000 after purchasing an additional 118 shares in the last quarter. Capital Analysts LLC lifted its stake in HCA Healthcare by 10.3% in the 2nd quarter. Capital Analysts LLC now owns 642 shares of the company’s stock valued at $250,000 after buying an additional 60 shares in the last quarter. NewEdge Advisors LLC increased its stake in HCA Healthcare by 6.5% during the 2nd quarter. NewEdge Advisors LLC now owns 9,918 shares of the company’s stock worth $3,867,000 after buying an additional 609 shares in the last quarter. IFP Advisors Inc boosted its stake in shares of HCA Healthcare by 4.1% in the second quarter. IFP Advisors Inc now owns 9,563 shares of the company’s stock worth $3,729,000 after acquiring an additional 377 shares during the last quarter. Finally, Empirical Finance LLC raised its stake in HCA Healthcare by 2.3% in the 2nd quarter. Empirical Finance LLC now owns 7,140 shares of the company’s stock valued at $2,784,000 after purchasing an additional 161 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Performance

HCA opened at $422.47 on Thursday. HCA Healthcare, Inc. has a one year low of $353.99 and a one year high of $556.52. The stock has a market capitalization of $91.47 billion, a PE ratio of 14.14, a P/E/G ratio of 1.32 and a beta of 1.10. The business’s 50 day moving average price is $404.41 and its 200 day moving average price is $434.23.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating the consensus estimate of $7.56 by $0.03. The business had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The company’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $6.84 EPS. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 29.42 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be issued a $0.78 dividend. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio is currently 10.45%.

Analyst Upgrades and Downgrades

HCA has been the subject of a number of recent research reports. Raymond James Financial set a $528.00 target price on shares of HCA Healthcare in a research report on Tuesday, July 7th. Morgan Stanley decreased their target price on shares of HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating on the stock in a research note on Monday, July 27th. Barclays dropped their price target on HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating for the company in a research report on Monday, July 27th. Truist Financial dropped their target price on HCA Healthcare from $535.00 to $495.00 and set a “buy” rating for the company in a report on Monday, July 27th. Finally, Deutsche Bank Aktiengesellschaft set a $476.00 price target on HCA Healthcare in a report on Monday, July 27th. Fourteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $462.64.

HCA Healthcare Company Profile

HCA Healthcare, Inc (NYSE:HCA) is a healthcare services company that operates hospitals and other healthcare facilities. Its network provides a broad range of medical services, including emergency care, inpatient and outpatient treatment, surgery, diagnostic services, and maternity care.

The company also operates ambulatory surgery centers, urgent care facilities, physician practices, and other outpatient locations. HCA Healthcare serves patients through facilities located across the United States, as well as through HCA Healthcare UK, its healthcare operations in the United Kingdom.

HCA Healthcare was founded in 1968 by Dr.